Cargando…

Cyclin E2 is the predominant E-cyclin associated with NPAT in breast cancer cells

BACKGROUND: The cyclin E oncogene activates CDK2 to drive cells from G(1) to S phase of the cell cycle to commence DNA replication. It coordinates essential cellular functions with the cell cycle including histone biogenesis, splicing, centrosome duplication and origin firing for DNA replication. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rogers, Samuel, Gloss, Brian S, Lee, Christine S, Sergio, Claudio Marcelo, Dinger, Marcel E, Musgrove, Elizabeth A, Burgess, Andrew, Caldon, Catherine Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349318/ https://www.ncbi.nlm.nih.gov/pubmed/25741376 http://dx.doi.org/10.1186/s13008-015-0007-9

Ejemplares similares

Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer
por: Caldon, C Elizabeth, et al.
Publicado: (2010)

Cyclin E2 Promotes Whole Genome Doubling in Breast Cancer
por: Lee, Christine, et al.
Publicado: (2020)

Interaction of Heat Shock Protein Cpn10 with the Cyclin E/Cdk2 Substrate Nuclear Protein Ataxia-Telangiectasia (NPAT) Is Involved in Regulating Histone Transcription
por: Ling Zheng, Li, et al.
Publicado: (2015)

High cyclin E1 protein, but not gene amplification, is prognostic for basal‐like breast cancer
por: Aziz, Diar, et al.
Publicado: (2022)

Putting Cyclin E in the trash
por: Leslie, Mitch
Publicado: (2013)

Limited redundancy in genes regulated by Cyclin T2 and Cyclin T1
por: Ramakrishnan, Rajesh, et al.
Publicado: (2011)

The Prognostic Value and Overexpression of Cyclin A Is Correlated with Gene Amplification of both Cyclin A and Cyclin E in Breast Cancer Patient
por: Husdal, A., et al.
Publicado: (2006)

Parallel cyclin E and cyclin A expression in neoplastic lesions of the uterine cervix
por: Erlandsson, F, et al.
Publicado: (2006)

Cyclin E Expression and Proliferation in Breast Cancer
por: Nielsen, Niels H., et al.
Publicado: (1998)

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models
por: Sutherland, Robert L, et al.
Publicado: (2002)

Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells
por: Kang, Jian, et al.
Publicado: (2014)

Expression of cyclin D1 and cyclin E in human gastric carcinoma and its clinicopathologic significance.
por: Ahn, M. J., et al.
Publicado: (1998)

Cyclin E as a Coactivator of the Androgen Receptor
por: Yamamoto, Ayako, et al.
Publicado: (2000)

Quantitative profiling of adaptation to cyclin E overproduction
por: Limas, Juanita C, et al.
Publicado: (2022)

Nuclear Import of Cdk/Cyclin Complexes: Identification of Distinct Mechanisms for Import of Cdk2/Cyclin E and Cdc2/Cyclin B1
por: Moore, Jonathan D., et al.
Publicado: (1999)

Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression
por: Yang, Liu, et al.
Publicado: (2015)

β-carotene Inhibits Expression of c-Myc and Cyclin E in Helicobacter pylori-infected Gastric Epithelial Cells
por: Kim, Dahye, et al.
Publicado: (2019)

Too Much Cleavage of Cyclin E Promotes Breast Tumorigenesis
por: Loeb, Keith R., et al.
Publicado: (2012)

Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factors
por: Boström, Pia, et al.
Publicado: (2009)

Stimulation of hERG1 channel activity promotes a calcium-dependent degradation of cyclin E2, but not cyclin E1, in breast cancer cells
por: Perez-Neut, Mathew, et al.
Publicado: (2015)

A Novel Interaction Between HER2/neu and Cyclin E in Breast Cancer
por: Mittendorf, Elizabeth A., et al.
Publicado: (2010)

Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma
por: Matsumoto, M, et al.
Publicado: (1999)

Cell cycle progression mechanisms: slower cyclin-D/CDK4 activation and faster cyclin-E/CDK2
por: Zhang, Wengang, et al.
Publicado: (2023)

Cyclin E1 regulates hematopoietic stem cell quiescence
por: Jayapal, Senthil Raja, et al.
Publicado: (2013)

Differences in regulation and function of E-cyclins in human cancer cells
por: Geng, Yan, et al.
Publicado: (2013)

Proteomic Landscape of Tissue-Specific Cyclin E Functions in Vivo
por: Odajima, Junko, et al.
Publicado: (2016)

Frequent Amplification of the Cyclin E Gene in Human Gastric Carcinomas
por: Akama, Yoshihiko, et al.
Publicado: (1995)

Characterisation of cyclin D1 down‐regulation in coronavirus infected cells
por: Harrison, Sally M., et al.
Publicado: (2007)

MicroRNA-195 Inhibits the Proliferation of Human Glioma Cells by Directly Targeting Cyclin D1 and Cyclin E1
por: Hui, Wang, et al.
Publicado: (2013)

Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression
por: Duan, Yujie, et al.
Publicado: (2016)

Cyclin C: The Story of a Non-Cycling Cyclin
por: Ježek, Jan, et al.
Publicado: (2019)

Cyclin-Dependent Kinase Inhibitors Induce Apoptosis in Plant Cells
por: Strnad, M., et al.
Publicado: (2001)

Purine Inhibitors of Cyclin-Dependent Kinase and Their Apoptosis and Cytotoxicity Mechanisms
por: Strnad, M., et al.
Publicado: (2001)

E2F1 proteolysis via SCF‐cyclin F underlies synthetic lethality between cyclin F loss and Chk1 inhibition
por: Burdova, Kamila, et al.
Publicado: (2019)

Cyclin D1, cyclin E, and p21 have no apparent prognostic value in anal carcinomas treated by radiotherapy with or without chemotherapy
por: Allal, A S, et al.
Publicado: (2004)

Down-regulation of SOSTDC1 promotes thyroid cancer cell proliferation via regulating cyclin A2 and cyclin E2
por: Liang, Weiwei, et al.
Publicado: (2015)

Molecular interaction studies of Deguelin and its derivatives with Cyclin D1 and Cyclin E in cancer cell signaling pathway: The computational approach
por: Lokhande, Kiran Bharat, et al.
Publicado: (2019)

Cyclin E expression is associated with high levels of replication stress in triple-negative breast cancer
por: Guerrero Llobet, Sergi, et al.
Publicado: (2020)

Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS
por: Taylor-Harding, Barbie, et al.
Publicado: (2014)

Deregulation of cyclin E in human cells interferes with prereplication complex assembly
por: Ekholm-Reed, Susanna, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_3bv9okv890ps4ov0m7o3g0un7c